Hand-Foot and Stump Syndrome to Sorafenib-Reference-Cited by-同舟云学术

Hand-Foot and Stump Syndrome to Sorafenib

Published:2007-01-20 Issue:3 Volume:25 Page:341-343
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lai Susan E.¹,Kuzel Timothy²,Lacouture Mario E.³

Affiliation:

1. Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL

2. Division of Hematology/Oncology, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL

3. Skin and Eye Reactions to Inhibitors of EGFR and Kinases (SERIES) Clinic and Cancer Skin Care Program, Robert H. Lurie Comprehensive Cancer Center and Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.08.9565

Reference7 articles.

1. Antineoplastic Chemotherapy, Sweat, and the Skin

2. Mucocutaneous side effects of antineoplastic chemotherapy

3. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?

4. Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor

5. Cutaneous side-effects of kinase inhibitors and blocking antibodies

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib;World Journal of Hepatology;2022-07-27

2. Assessment of Skin Toxicity in an in Vitro Reconstituted Human Epidermis Model Using Deep Learning;The American Journal of Pathology;2022-04

3. Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database;Therapeutic Advances in Drug Safety;2022-01

4. Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer;Frontiers in Oncology;2021-04-26

5. Dermatological Toxicities of Targeted Therapy;Handbook of Cancer Treatment-Related Symptons and Toxicities;2020